- Home
- NARI
NARI
Inari Medical Inc.
as 12-26-2024 11:40am EST
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 3.3B | IPO Year: | 2020 |
| Target Price: | $62.33 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $36.73 - $66.61 | Next Earning Date: | 10-28-2024 |
| Revenue: | $574,498,000 | Revenue Growth: | 22.41% |
| Revenue Growth (this year): | 24.62% | Revenue Growth (next year): | 18.21% |
Stock Insider Trading Activity of Inari Medical Inc. (NARI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hoffman William | NARI | Director | Dec 16 '24 | Sell | $55.74 | 60,000 | $3,339,704.45 | 461,233 | |
| Tu Thomas | NARI | Chief Medical Officer | Dec 10 '24 | Sell | $55.00 | 4,000 | $220,000.00 | 304,036 | |
| Hykes Andrew | NARI | President and CEO | Nov 20 '24 | Sell | $50.83 | 3,000 | $152,490.00 | 442,310 | |
| Hoffman William | NARI | Director | Nov 18 '24 | Sell | $51.06 | 60,000 | $3,069,520.64 | 461,233 | |
| Hoffman William | NARI | Director | Oct 29 '24 | Sell | $50.05 | 40,000 | $2,002,000.00 | 461,233 | |
| Hykes Andrew | NARI | President and CEO | Oct 29 '24 | Sell | $50.00 | 3,000 | $150,000.00 | 442,310 | |
| Hoffman William | NARI | Director | Oct 16 '24 | Sell | $45.18 | 40,000 | $1,800,834.84 | 461,233 |
Latest Inari Medical Inc. News
NARI Breaking Stock News: Dive into NARI Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
NARI: Lowering target price to $43.00
TipRanks
7 days ago
Inari Medical price target raised to $63 from $50 at Truist
MT Newswires
7 days ago
Inari Medical Insider Sold Shares Worth $3,339,704, According to a Recent SEC Filing
MT Newswires
8 days ago
Truist Securities Raises Price Target on Inari Medical to $63 From $50, Keeps Hold Rating
Argus Research
9 days ago
NARI: Raising target price to $45.00
MT Newswires
9 days ago
Oppenheimer Initiates Coverage on Inari Medical With Outperform Rating, $75 Price Target
Investor's Business Daily
15 days ago
Inari Medical Stock Gets RS Rating Upgrade
Argus Research
16 days ago
NARI: Raising target price to $44.00
Compare NARI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NARI Inari Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.